![]() |
|
|









* Division of Nutritional Sciences, Cornell University, Ithaca, NY;
Department of Nutritional Sciences and Toxicology, University of California, Berkeley, CA;
** Channing Laboratory, Brigham and Womens Hospital and Harvard Medical School, Boston, MA;
Brigham and Womens Hospital, Division of Aging, Boston, MA;

Department of Biological Statistics and Computational Biology, Cornell University, Ithaca, NY; and

Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, MA
2To whom correspondence should be addressed. E-mail: pac6{at}cornell.edu.
Genetic variation in folate-regulating enzymes contributes to the risk of cardiovascular disease (CVD). The cytoplasmic serine hydroxymethyltransferase (cSHMT) enzyme is proposed to regulate a key metabolic intersection in folate metabolism. We hypothesized that a variant in cSHMT (cSHMT 1420C
T) affects CVD risk, and that the effect depends on a linked step in the metabolic pathway catalyzed by methylenetetrahydrofolate reductase (MTHFR). A nested case-control study of incident CVD was conducted within the all-male Normative Aging Study cohort. Of the incident CVD cases, 507 had DNA samples; 2 controls/case were selected by risk set sampling (matched on age and birth year). A significant gene-gene interaction (P-values 0.0013, 0.0064) was found between MTHFR and cSHMT, and there was little or no change in the coefficients in covariate-adjusted models. The effect of MTHFR 677C
T genotype on CVD risk varied by cSHMT 1420C
T genotype. Among men with cSHMT 1420C
T TT genotype, the odds ratios (OR) for CVD risk for MTHFR 677C
T CT and TT genotypes compared with the MTHFR 677C
T CC genotype were 3.6 (95% CI, 1.77.8) and 10.6 (95% CI, 2.546.0), respectively. Among men with the cSHMT 1420C
T CC/CT genotype, the corresponding ORs were 1.0 (95% CI, 0.81.2) and 1.3 (95% CI, 0.91.8). Plasma total homocysteine concentrations were highest in the subgroup of men with both polymorphisms, MTHFR 677C
T TT and cSHMT 1420C
T TT, consistent with a higher risk of CVD in this subgroup. A more complete understanding of the molecular mechanism awaits identification of the functional effect of the polymorphism.
KEY WORDS: homocysteine folate men cardiovascular disease
This article has been cited by other articles:
![]() |
A. Baccarelli, P. A. Cassano, A. Litonjua, S. K. Park, H. Suh, D. Sparrow, P. Vokonas, and J. Schwartz Cardiac Autonomic Dysfunction: Effects From Particulate Air Pollution and Protection by Dietary Methyl Nutrients and Metabolic Polymorphisms Circulation, April 8, 2008; 117(14): 1802 - 1809. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Kelemen, T. A. Sellers, J. M. Schildkraut, J. M. Cunningham, R. A. Vierkant, V. S. Pankratz, Z. S. Fredericksen, M. K. Gadre, D. N. Rider, M. Liebow, et al. Genetic Variation in the One-Carbon Transfer Pathway and Ovarian Cancer Risk Cancer Res., April 1, 2008; 68(7): 2498 - 2506. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Woeller, D. D. Anderson, D. M. E. Szebenyi, and P. J. Stover Evidence for Small Ubiquitin-like Modifier-dependent Nuclear Import of the Thymidylate Biosynthesis Pathway J. Biol. Chem., June 15, 2007; 282(24): 17623 - 17631. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Lim, S. S. Wang, P. Hartge, W. Cozen, L. E. Kelemen, S. Chanock, S. Davis, A. Blair, M. Schenk, N. Rothman, et al. Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER Case-Control Study Blood, April 1, 2007; 109(7): 3050 - 3059. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Reed, H. F. Nijhout, M. L. Neuhouser, J. F. Gregory III, B. Shane, S. J. James, A. Boynton, and C. M. Ulrich A Mathematical Model Gives Insights into Nutritional and Genetic Aspects of Folate-Mediated One-Carbon Metabolism J. Nutr., October 1, 2006; 136(10): 2653 - 2661. [Abstract] [Full Text] [PDF] |
||||